Sildenafil, the erectile dysfunction drug sold as Viagra and now under consideration as a treatment for heart failure, affects males and females very differently, reveals a new study.
According to the cardiovascular researchers of Johns Hopkins University, in female mice modeling human heart failure, the benefits of sildenafil ranged from robust to practically nonexistent, depending on the animals' levels of the hormone estrogen.
Viagra as Treatment for Heart Failure Affects Males and Females Differently
Erectile dysfunction drug sildenafil, better known as Viagra, which is currently being considered as a treatment for heart failure affects males and females differently.
Lead scientist Eiki Takimoto said that sildenafil generally appears to work well, but only because it targets a different biological process independent of estrogen in males.
He said that the research is especially significant because it offers a mechanism to explain how estrogen affects sildenafil's efficacy and its the first time the actual pathway of a hormone's cause and effect on a drug has been mapped out.
The study was published in The Journal of Clinical Investigation.
Source: ANI
The study was published in The Journal of Clinical Investigation.
Source: ANI
Viagra can Treat Duchenne Muscular Dystrophy: Study
In boys with muscle-wasting disorder, Viagra and Cialis can be used to fight the disorder, says study.
 Ice Cream That Could Serve as a Replacement for Viagra DevelopedThe Arousal, the new ice cream flavour developed by a British ice cream maker includes 25 mg of Viagra per scoop. |
People Throng Twitter, Pinterest to Find Viagra News
To get information about Viagra and its benefits, people go to general social networking sites like Twitter and Pinterest, research shows.
Recommended Reading
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.
